Max Kevane-Campbell

Max Kevane-Campbell is a PhD student at the Department of Infectious Diseases and the Institute of Medical Microbiology and Infection Control, University Hospital Frankfurt. His research concentrates on resistance determinants, plasmid pathogenicity and phage therapy of non-tuberculous mycobacteria.

miru associated

Publications

The state of leprosy: increasing trends of Hansen’s disease in Florida, USA, 1996-2025

Nov 6, 2026

Max Kevane-Campbell, Siti Setyawati Mulyono Putri, Dylan Buck, Raja Idris, Thomas Wichelhaus, Jorge Cervantes, Nils Wetzstein

PLOS Neglected Tropical Diseases

Epidemiological investigation of leprosy cases in the state of Florida, USA.

Exploring the next “phage” of treating non-tuberculous mycobacterial infections

Jun 1, 2026

Max Kevane-Campbell, Raja Idris, Silvia Würstle, Simone Lieberknecht, Maria J.G.T. Vehreschild, Thomas Wichelhaus, Nils Wetzstein

In Infection

Review on phage therapy for NTM infections

Genomic population structure, antimicrobial susceptibility, and clinical features of Mycobacterium xenopi isolates, Frankfurt, Germany, 1995-2020

Feb 9, 2026

Margo Diricks, Lisa Marschall, Teodora Biciusca, Ann-Sophie Zielbauer, Max Kevane-Campbell, Martin Kuhns, Sönke Andres, Stefan Niemann, Thomas Wichelhaus, Nils Wetzstein

In Journal of Clinical Microbiology

M. xenopi genomics and antimicrobial susceptibility.